· Dolphin Sutures
The package is part of the device: sterile barrier systems
A sterile device is only sterile until its packaging fails. Barrier materials, seal validation, shelf life and aseptic presentation are engineering work, not procurement.
· Dolphin Sutures
A sterile device is only sterile until its packaging fails. Barrier materials, seal validation, shelf life and aseptic presentation are engineering work, not procurement.

A device that has been sterilised is sterile only for as long as what surrounds it keeps microorganisms out and survives being shipped, stored and opened. That makes packaging a functional part of the device rather than what it arrives in — a point the regulatory framework takes seriously and purchasing conversations often do not.
The terminology is precise, and worth using precisely. The sterile barrier system is the minimum packaging that maintains sterility and permits aseptic presentation — for a suture, typically the sealed inner pack. Protective packaging is everything outside it that stops the barrier being damaged. Together they form the packaging system, and only the barrier is doing the sterility work.
This is why a crushed outer carton and a crushed inner pack are entirely different events, and why staff are trained to treat them differently.
Barrier materials have to satisfy two requirements that pull against each other: they must be impermeable to microorganisms, and — for gas sterilisation — permeable enough to let the sterilant in and out.
Porous non-woven materials resolve this by having a tortuous pore structure: gas passes through, particles and organisms do not travel the path. Paired with a transparent polymer film, this gives the peel pouch familiar throughout hospitals.
Where the device is radiation-sterilised, gas permeability is unnecessary and fully impermeable structures become available. Foil laminates are used where moisture ingress matters — which is the case for materials whose properties change with humidity, absorbable sutures among them. A foil pack is not a premium presentation; it is a moisture barrier doing a job.
Most sterile barrier failures are seal failures, which is why sealing is one of the most tightly controlled processes in a device plant.
A heat seal is produced by temperature, pressure and dwell time, and all three are validated and monitored continuously rather than checked at the end. Seal strength is specified as a window, not a minimum: too weak and it may open in transit, too strong and it tears the material on opening instead of peeling cleanly — which can shed fibres into a sterile field. Peelability is a specification with a patient-safety rationale.
An expiry date on a sterile device is a claim about the packaging as much as about the contents, and it has to be supported by evidence.
Real-time ageing — storing product and testing it at intervals across the claimed life — is the reference method and takes as long as the claim. Accelerated ageing at elevated temperature is used to support a claim before real-time data exists, on established modelling assumptions, with real-time testing continuing in parallel to confirm it. Both are then combined with transport simulation, because a package that survives a shelf and a package that survives a supply chain are different tests.
The last function of the barrier is the one performed in theatre: the pack has to open so that the contents can be transferred to a sterile field without contact between the outside of the pack and the device.
That imposes design requirements that are easy to overlook — peel direction, the shape of the opening, where the device sits inside, and whether the pack can be presented one-handed by a scrub nurse. It is validated with people opening packs, because it is a human-factors requirement, not a materials one.
The pack is also the primary information carrier: device identification and size, sterilisation method, expiry, lot number, unique device identification in both human-readable and machine-readable form, and the symbols that communicate single use, do-not-resterilise and do-not-use-if-damaged across languages.
Two current pressures act on that surface simultaneously. Regulatory requirements keep adding to what must appear, and sustainability programmes ask for less material. Reconciling more required information with less printable area is a genuine constraint, and it is why label and pack design are increasingly treated as a single engineering problem.
Because packaging failure presents as product failure. A device that arrives with a compromised pack is unusable regardless of its quality, and consistency of sealing and pack integrity across shipments is one of the more revealing measures of a supplier’s process control — visible in receiving inspection long before anything else is.
Dolphin Sutures' manufacturing and packaging controls are described on the quality page.
This article summarises developments reported publicly across the medical-device trade press, conference programmes and clinical literature. It is general professional information — not clinical guidance, and not a claim about any Dolphin Sutures product. Device selection, indications and technique rest with the treating surgeon; refer to the Instructions for Use supplied with any device.
Bulk pricing, OEM manufacturing and export documentation — response within one business day.